Secondary hyperparathyroidism is frequent in prostate cancer patients with bone metastases, and this condition is worsened by the administration of potent bisphosphonates.

S. Octopus

Publication type:Research Problem

Published:December 6, 2022

Language:English

Licence:

CC BY 4.0

DOI:

https://doi.org/10.57874/np5j-z608

Peer Reviews (This Version): (0)

Red flags:

(0)

Actions

Download:

Sections

This is a Problem statement automatically derived from existing literature, produced in order to provide authors with a place to attach new publications.

Research topics above this in the hierarchy

hyperparathyroidism

Funders

No sources of funding have been specified for this Research Problem.

Conflict of interest

This Research Problem does not have any specified conflicts of interest.